Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition-Reference-Cited by-同舟云学术

Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition

Published:2021-01-27 Issue:7846 Volume:590 Page:486-491
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Cohen-Sharir Yael,McFarland James M.^ORCID,Abdusamad Mai,Marquis Carolyn,Bernhard Sara V.,Kazachkova Mariya,Tang Helen,Ippolito Marica R.,Laue Kathrin,Zerbib Johanna,Malaby Heidi L. H.,Jones Andrew,Stautmeister Lisa-Marie,Bockaj Irena,Wardenaar René,Lyons Nicholas,Nagaraja Ankur^ORCID,Bass Adam J.^ORCID,Spierings Diana C. J.^ORCID,Foijer Floris^ORCID,Beroukhim Rameen^ORCID,Santaguida Stefano^ORCID,Golub Todd R.^ORCID,Stumpff Jason,Storchová Zuzana^ORCID,Ben-David Uri^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-020-03114-6.pdf

Reference75 articles.

1. Ben-David, U. & Amon, A. Context is everything: aneuploidy in cancer. Nat. Rev. Genet. 21, 44–62 (2020).

2. Ghandi, M. et al. Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature 569, 503–508 (2019).

3. Tsherniak, A. et al. Defining a cancer dependency map. Cell 170, 564–576.e16 (2017).

4. McDonald, E. R. III et al. Project DRIVE: a compendium of cancer dependencies and synthetic lethal relationships uncovered by large-scale, deep RNAi screening. Cell 170, 577–592.e10 (2017).

5. Aguirre, A. J. et al. Genomic copy number dictates a gene-independent cell response to CRISPR/Cas9 targeting. Cancer Discov. 6, 914–929 (2016).

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of inhibitors targeting KIF18A with ploidy-specific lethality;Drug Discovery Today;2024-10

2. Human aneuploid cells depend on the RAF/MEK/ERK pathway for overcoming increased DNA damage;Nature Communications;2024-09-09

3. Identification of KIFC1 as a putative vulnerability in lung cancers with centrosome amplification;Cancer Gene Therapy;2024-08-24

4. Meeting proceedings of the 43rd Indian Association for Cancer Research (IACR);Biology Open;2024-08-14

5. Dual TTK/PLK1 inhibition has potent anticancer activity in TNBC as monotherapy and in combination;Frontiers in Oncology;2024-08-09